Literature DB >> 16941028

Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1).

A-M Kuusniemi1, J Merenmies, A-T Lahdenkari, C Holmberg, K Salmela, R Karikoski, J Rapola, H Jalanko.   

Abstract

Congenital nephrotic syndrome of the Finnish type (NPHS1) is a rare genetic disease caused by mutations in the NPHS1 gene encoding a major podocyte slit-diaphragm protein, nephrin. Patients with NPHS1 have severe nephrotic syndrome from birth and develop renal fibrosis in early childhood. In this work, we studied the development of glomerular sclerosis in kidneys removed from 4- to 44-month-old NPHS1 patients. The pathological lesions and expression of glomerular cell markers were studied in nephrectomized NPHS1 and control kidneys using light and electron microscopy and immunohistochemistry. An analysis of 1528 glomeruli from 20 patients revealed progressive mesangial sclerosis and capillary obliteration. Although few inflammatory cells were detected in the mesangial area, paraglomerular inflammation and fibrosis was common. The podocytes showed severe ultrastructural changes and hypertrophy with the upregulation of cyclins A and D1. Podocyte proliferation, however, was rare. Apoptosis was hardly detected and the expression of antiapoptotic B-cell lymphoma-2 and proapoptotic p53 were comparable to controls. Moderate amounts of podocytes were secreted into the urine of NPHS1 patients. Shrinkage of the glomerular tuft was common, whereas occlusion of tubular opening or protrusion of the glomerular tuft into subepithelial space or through the Bowman's capsule were not detected. The results indicate that, in NPHS1 kidneys, the damaged podocytes induce progressive mesangial expansion and capillary obliteration. Podocyte depletion, glomerular tuft adhesion, and misdirected filtration, however, seem to play a minor role in the nephron destruction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941028     DOI: 10.1038/sj.ki.5001779

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

2.  Podocyte proteins in congenital and minimal change nephrotic syndrome.

Authors:  Maija Suvanto; Timo Jahnukainen; Marjo Kestilä; Hannu Jalanko
Journal:  Clin Exp Nephrol       Date:  2014-08-14       Impact factor: 2.801

3.  Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells.

Authors:  Robert Koesters; Brigitte Kaissling; Michel Lehir; Nicolas Picard; Franziska Theilig; Rolf Gebhardt; Adam B Glick; Brunhilde Hähnel; Hiltraud Hosser; Hermann-Josef Gröne; Wilhelm Kriz
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

4.  Changes in glomerular mesangium in kidneys with congenital nephrotic syndrome of the Finnish type.

Authors:  Anne Kaukinen; Arvi-Matti Kuusniemi; Heikki Helin; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2009-12-18       Impact factor: 3.714

5.  Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome.

Authors:  Géraldine Mollet; Julien Ratelade; Olivia Boyer; Andrea Onetti Muda; Ludivine Morisset; Tiphaine Aguirre Lavin; David Kitzis; Margaret J Dallman; Laurence Bugeon; Norbert Hubner; Marie-Claire Gubler; Corinne Antignac; Ernie L Esquivel
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

6.  Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome.

Authors:  Saskia F Heeringa; Christopher N Vlangos; Gil Chernin; Bernward Hinkes; Rasheed Gbadegesin; Jinhong Liu; Bethan E Hoskins; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2008-05-23       Impact factor: 5.992

7.  Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Authors:  Youli Wang; Kathleen O Heilig; Andrew W Minto; Shenglin Chen; Minghui Xiang; David A Dean; Richard C Geiger; Anthony Chang; Dimitrina D Pravtcheva; Martin Schlimme; Dilip K Deb; Ying Wang; Charles W Heilig
Journal:  Lab Invest       Date:  2009-11-16       Impact factor: 5.662

8.  Activated omentum slows progression of CKD.

Authors:  Ignacio Garcia-Gomez; Nishit Pancholi; Jilpa Patel; Krishnamurthy P Gudehithlu; Periannan Sethupathi; Peter Hart; George Dunea; Jose A L Arruda; Ashok K Singh
Journal:  J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 10.121

9.  Triptolide Attenuates Podocyte Injury by Regulating Expression of miRNA-344b-3p and miRNA-30b-3p in Rats with Adriamycin-Induced Nephropathy.

Authors:  Chun-Bo Jiang; Ming-Gang Wei; Yue Tu; Hao Zhu; Chun-Qing Li; Wei-Min Jing; Wei Sun
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-20       Impact factor: 2.629

10.  Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS).

Authors:  Dominik S Schoeb; Gil Chernin; Saskia F Heeringa; Verena Matejas; Susanne Held; Virginia Vega-Warner; Detlef Bockenhauer; Christopher N Vlangos; Khemchand N Moorani; Thomas J Neuhaus; Jameela A Kari; James MacDonald; Pawaree Saisawat; Shazia Ashraf; Bugsu Ovunc; Martin Zenker; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2010-02-18       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.